Cumulative 5-year stakeholder savings are largely similar for COPD patients treated with NIPPV (AVAPS-AE) versus No NIV or RAD (Bi-level positive pressure) - A Budget Impact Model from the Hospital, DME Provider, and Payer Perspective - Home NIV Therapy for COPD Resource Center